Cite

HARVARD Citation

    Gusella, M. et al. (2020). Predicting steady‐state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?. Pharmacology research & perspectives. 8 (5), p. n/a. [Online]. 
  
Back to record